BioMAP Toxicity Signature Analysis Around the Globe: Responding to Our International Team
Our Eurofins Discovery team in Japan presented at the 2021 Japanese Safety Pharmacology Society Annual Meeting, where they had the opportunity to... Read More
Pushing Forward for Preclinical Human Data
Reduce, Reuse, Recycle. These are the three Rs familiar to many with reference to best practices associated with environmental stewardship and a... Read More
Phenotypic Profiling Identifies Biomarkers and Mechanisms of Toxicity
Analysis shows why failed drug candidates cause adverse skin reactions, and yields biomarker signature to detect problems with future candidates early in... Read More
Biological Validation of the BioMAP® Platform with Phenotypic Chemical Probes
Phenotypic chemical biology is the use of target-selective chemical probes and drugs in cell-based or in vivo assays for establishing target function... Read More
Five Reasons to Implement In Vitro Phenotypic Screening in Preclinical Safety
Reason 1 – Animals Aren’t Predictive of Humans Rodents, in particular, are small, do not live long, and are typically housed in... Read More
Phenotypic Profiling is on the Rise!
Three terrific review articles that explain why pharma is moving from target to phenotype For some years now, there has been a... Read More
3 Key Trends in Drug Discovery Outsourcing for 2016
In 2011 the pharmaceutical industry was presented with a major challenge. The peak of the patent cliff was approaching with over $30... Read More
Best Conferences for Learning about Phenotypic Profiling
Just a few of the places DiscoverX will be this year where we want to meet YOU! DiscoverX will be traveling the... Read More